Igietseme J U, Calzada P J, Gonzalez A R, Streilein J W, Atherton S S
Department of Microbiology and Immunology, University of Miami School of Medicine, Florida 33136.
J Virol. 1989 Nov;63(11):4808-13. doi: 10.1128/JVI.63.11.4808-4813.1989.
A form of acute retinal necrosis occurred in the contralateral eyes of susceptible mice 1 week after each received a uniocular injection of live herpes simplex virus type 1 (HSV-1) in the anterior chamber. Although these mice did not develop systemic delayed hypersensitivity to virus antigens, their sera contained virus-specific antibodies at the time contralateral retinitis occurred. These findings suggest that systemic immunity might not be able to protect against contralateral retinitis. To explore this possibility further, we examined lymph nodes and spleens of intraocularly infected mice to determine whether their lymphoid tissues contained primed HSV-1-specific cytotoxic T cells. Virus-specific cytotoxic T cells were readily identified in these mice. We wondered why successful immune priming did not confer protection against HSV-1 retinitis. We examined this issue by evaluating the capacity of in vitro-generated, HSV-1-specific effector T cells to prevent retinitis by infusing these cells by various routes and at various times into mice that received an intracameral injection of HSV-1. The results revealed that virus-specific effector cells could prevent contralateral retinitis if injected intravenously or into the anterior chamber of the contralateral eye at the same time that virus was injected into one eye. However, the effector cells failed to prevent retinitis if they were injected into the same eye that received HSV-1 or if their intravenous administration was delayed until 24 h after the HSV-1 injection into the eye. We concluded that immune T cells can protect against contralateral retinal necrosis caused by uniocular injection of HSV-1 into the anterior chamber but only if they are administered during the first 24 h after virus infection. We propose that a retinitis-inducing process is set in motion during this early time interval postinfection. Once the process has been initiated and established, it is no longer susceptible to immune intervention. It would appear that mice that are susceptible to contralateral retinitis fail to mobilize a protective response quickly enough to ward off the establishment of the retinitis-inducing process and its disastrous eventuality.
将单纯疱疹病毒1型(HSV-1)前房单眼注射到易感小鼠体内1周后,对侧眼发生了一种急性视网膜坏死。尽管这些小鼠未对病毒抗原产生全身性迟发型超敏反应,但在对侧视网膜发生炎症时,它们的血清中含有病毒特异性抗体。这些发现表明,全身免疫可能无法预防对侧视网膜炎症。为进一步探究这种可能性,我们检查了眼内感染小鼠的淋巴结和脾脏,以确定其淋巴组织中是否含有经致敏的HSV-1特异性细胞毒性T细胞。在这些小鼠中很容易鉴定出病毒特异性细胞毒性T细胞。我们想知道为什么成功的免疫致敏不能预防HSV-1视网膜炎症。我们通过评估体外产生的HSV-1特异性效应T细胞通过各种途径并在不同时间注入接受前房注射HSV-1的小鼠体内来预防视网膜炎症的能力,来研究这个问题。结果显示,如果在向一只眼睛注射病毒的同时静脉注射或注入对侧眼前房,病毒特异性效应细胞可以预防对侧视网膜炎症。然而,如果将效应细胞注射到接受HSV-1的同一只眼睛中,或者将其静脉给药延迟到向眼睛注射HSV-1后24小时,则效应细胞无法预防视网膜炎症。我们得出结论,免疫T细胞可以预防前房单眼注射HSV-1引起的对侧视网膜坏死,但前提是在病毒感染后的头24小时内给药。我们认为,在感染后的这个早期时间间隔内,一个诱导视网膜炎症的过程就已经启动。一旦这个过程启动并确立,它就不再易受免疫干预。似乎易患对侧视网膜炎症的小鼠未能足够迅速地调动保护性反应来抵御诱导视网膜炎症的过程及其灾难性后果。